FMP

FMP

Enter

CNMD - CONMED Corporation

photo-url-https://images.financialmodelingprep.com/symbol/CNMD.png

CONMED Corporation

CNMD

NYSE

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

57.08 USD

-0.67 (-1.17%)

Latest CNMD News

Zacks Investment Research

Aug 19, 2024

New Strong Sell Stocks for August 19th

ARRY, BSM and CNMD have been added to the Zacks Rank #5 (Strong Sell) List on August 19, 2024.

Read More

Zacks Investment Research

Aug 15, 2024

New Strong Sell Stocks for August 15th

ARCO, CNMD and CVS have been added to the Zacks Rank #5 (Strong Sell) List on August 15, 2024.

Read More

Zacks Investment Research

Aug 5, 2024

New Strong Sell Stocks for August 5th

AMX, CNH and CNMD have been added to the Zacks Rank #5 (Strong Sell) List on August 5, 2024.

Read More

Zacks Investment Research

Aug 1, 2024

CONMED (CNMD) Q2 Earnings Beat, Sales Rise Y/Y, '24 View Cut

CONMED (CNMD) beats second-quarter earnings estimates on the back of higher revenues and lower costs and expenses. However, the result reflects the continued impact of supply chain issues.

Read More

Zacks Investment Research

Jul 31, 2024

Here's What Key Metrics Tell Us About Conmed (CNMD) Q2 Earnings

Although the revenue and EPS for Conmed (CNMD) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Read More

Zacks Investment Research

Jul 31, 2024

Conmed (CNMD) Q2 Earnings Beat Estimates

Conmed (CNMD) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.83 per share a year ago.

Read More

Zacks Investment Research

Jul 24, 2024

Conmed (CNMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Read More

Zacks Investment Research

Jun 27, 2024

Here's Why You Should Retain CONMED (CNMD) Stock for Now

CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.

Read More

InvestorPlace

May 19, 2024

Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit Gains

Following the so-called “smart money” is often a wise strategy for retail investors. Most individual investors fail to outperform the broader market over the long-run.

Read More

Zacks Investment Research

Apr 25, 2024

CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates

CONMED's (CNMD) adjusted first-quarter earnings and revenues beat estimates on the back of strong U.S. and International markets as well as supply-chain improvement.

Read More
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep